Management of iron overload in myelodysplastic syndromes: combined deferasirox and deferoxamine in a patient with liver disease

Benzer Materyaller

• Reply to the letter to the editor “chronic disseminated candidiasis” by Kenneth Rolston
  Yazar:: Della Pepa, Roberta, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience
  Yazar:: Cerchione, Claudio, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Comparison of the effects of deferasirox, deferoxamine, and combination of deferasirox and deferoxamine on an aplastic anemia mouse model complicated with iron overload
  Yazar:: Wu, Dijiong, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Deferasirox for managing iron overload in people with myelodysplastic syndrome
  Yazar:: Meerpohl, Joerg J, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overload
  Yazar:: Aydinok, Yesim, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)